Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide.
Martínez-López J, Rivero A, Rapado I, Montalbán C, Paz-Carreira J, Canales M, Martínez R, Sánchez-Godoy P, Fernández de Sevilla A, Peñalver FJ, Gonzalez M, Prieto E, Salar A, Burgaleta C, Queizán JA, Peñarrubia MJ, Monteagudo MD, Cabrera C, De la Serna J, Tomás JF.
Martínez-López J, et al. Among authors: paz carreira j.
Leuk Lymphoma. 2009 Aug;50(8):1283-9. doi: 10.1080/10428190903040006.
Leuk Lymphoma. 2009.
PMID: 19557622